Irving-based Fluor Corporation announced Thursday that it has been awarded over $1 billion in two different life sciences contracts recently.
The larger project of the two involves mobilizing resources in the central U.S. “for the first phase of a new life sciences production facility valued at $574 million,” Fluor stated.
The other contract, for $487 million, involves a biotech expansion project in Denmark.
Richard Meserole, president of Fluor’s advanced technologies and life sciences business, said his company is excited to see “the significant investments being made globally in the production of cutting-edge technologies and pharmaceuticals that will improve the lives of billions of people.”
“Delivering these projects will help to increase the speed-to-market and meet the overwhelming demand for new medicines,” Meserole added in a statement.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.
R E A D N E X T
-
Expanding a collaboration they announced in January, the two companies aim to drive "the future of cancer care" with the new platform, enabling novel insights for precision medicine, therapeutic development, and clinical trials management for academic and biopharma researchers.
-
The $110 million, 135,000 square-foot expansion at Pegasus Park—a regional hub for life sciences and biotechnology in North Texas—will offer prebuilt lab suites with the tools and flexible space needed for growth-stage life sciences entrepreneurs and companies. Demolition is underway and construction on Bridge Labs is set to begin soon, developers said.
-
Dallas-based alternative investment firm NexPoint has revealed details and renderings of its planned 200-acre TxS District, short for "Technology x Science." Centered on the former headquarters campus of EDS in Plano's Legacy development, the life sciences hub could eventually offer over 4 million square feet of lab, office, and therapeutic production space. "Not only would this project be a major economic catalyst for the region, but it would also establish North Texas as a leader in life sciences," says James Dondero, NexPoint founder and principal.
-
The once-a-year summit on September 22 and 23 is an innovation multiplier for capital, collaboration, and commercialization. Experts in the field will discuss strategy and exchange insights—and what's driving life science success across the region.
-
The report names Dallas-Fort Worth as "a top emerging life sciences market in terms of size, institutions, talent, and rapid growth, alongside Nashville and Atlanta." According to Chelsea Story, VP with CBRE’s Life Sciences practice in Dallas, "DFW has all of the pieces assembled to become a dominant force in the life sciences sector."
